NCT00056875
- Conditions
- Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
- Locations
-
- University of Michigan Cancer Center Ann Arbor, Michigan, United States
Clinical trial condition
Graft Versus Host Disease
Explore clinical trials studying Graft Versus Host Disease. Study availability and eligibility vary by location and protocol.
129 public trials
12 recruiting studies
Graft Versus Host Disease trial results
- Conditions
- Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +9 more
- Locations
-
Not specified
NCT00589563
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
- Locations
-
- Banner Good Samaritan Medical Center Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT00824889
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Contact Dermatitis, +27 more
- Locations
-
- Service de Dermatologie- Hopital Sainte Marguerite Marseille, France
NCT00282282
- Conditions
- GVHD, Graft Versus Host Disease, Graft vs Host Disease, +1 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00265837
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT01135641
- Conditions
- Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
- Locations
-
- Nantes University Hospital Nantes, France
NCT01233921
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00438958
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
- Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
- Royal Melbourne Hospital Parkville, Victoria, Australia
- Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada
Completed
Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
NCT00031824
- Conditions
- Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
- Locations
-
- Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Southern California Permanente Medical Group Downey, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States